Immunoscore® is now available in Rectal Cancer for expert clinical centers through an Innovation Access Program Immunoscore® heads up to become the standard precision tool for the “Watch and Wait” strategy in locally...

Positive results on Immunoscore® in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France cohort study have been presented at ASCO 2019 HalioDx SAS, an immuno-oncology company pioneering the immunological...